X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Canada’s chance to reform its approach to innovation

By Jay Taylor  |    February 5, 2016
Intellectual property drives and sustains research, development and delivery of valuable new treatments and cures for patients who need them around the world. America’s world-leading research-based...   Read More

5 Reasons why biopharmaceutical patents are different

By Mark Grayson  |    September 10, 2015
Intellectual property protection has deep, historical roots in the United States.  Article I, Section 8 of the U.S. Constitution expressly recognizes the role of patents to “promote the Progress of...   Read More

Fact Check Friday: The Truth about IPR and Biopharmaceutical Patents

By Tina Stow  |    July 31, 2015
Today, we’re pleased to be kicking off our newest Catalyst blog series: Fact Check Friday. We’ll be using this space to separate truth from fiction and set the record straight when the rhetoric...   Read More

Patient Groups, Members of Congress and Other State-Based Stakeholders Agree: Stop the Abuse of Biopharmaceutical Patents

By Tina Stow  |    July 28, 2015
As Congress considers patent legislation known as H.R. 9, the Innovation Act, and S. 1137, the PATENT Act, health care leaders – from patient groups to Members of Congress to trade associations –...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    May 22, 2015
High Out-of-Pocket Costs Hurt Patients: Even with health coverage, approximately 31 million Americans were considered “underinsured” last year due to high deductibles and increasing out-of-pocket...   Read More

Patents: More Important to Biopharmaceutical Sector than Other Industries

By Setareh Samii  |    May 18, 2015
According to Abraham Lincoln, the patent system “secured to the inventor for a limited time exclusive use of his inventions, and thereby added the fuel of interest to the fire of genius in the...   Read More

Voters Agree: Congress Should Protect Patents

By Robert Zirkelbach  |    May 12, 2015
A recent poll by the Morning Consult confirms what is likely intuitive to most: strong intellectual property (IP) rights are important to voters for a variety of reasons. In the recent poll, a strong...   Read More

ICYMI: A Broad Coalition of Stakeholders Continue to Raise Concerns about Patent Litigation Reform

By Tina Stow  |    April 30, 2015
As we’ve shared here, here and here on the Catalyst, Congress is currently considering new patent litigation reform legislation. The Innovation Act (H.R. 9) will soon be marked up in the U.S. House...   Read More

World IP Day: The Foundation of Modern Life in America

By Mark Grayson  |    April 30, 2015
This week marks the celebration of  World Intellectual Property Day – an opportunity to reflect on and highlight the many ways that patents and trademarks serve as the very foundation of modern life...   Read More

What They Are Saying: Close Patent Loopholes That Threaten Innovation for Patients

By Robert Zirkelbach  |    April 29, 2015
“When we developed these proceedings, we never thought people would use them this way” -  Former general counsel of the PTO New administrative proceedings at the Patent and Trademark Office (PTO)...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."